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Background
Focal myocardial fibrosis is frequently observed in
dilated cardiomyopathy (DCM) and predicts future
major adverse cardiovascular events and patient out-
come. However, the pathogenesis of fibrosis in DCM
remains poorly understood. Novel serum biomarkers of
fibrosis such as Endoglin have been recently identified
as a trigger of myocardial fibrosis in heart failure.
Accordingly, we sought to investigate the relationship
between myocardial tissue fibrosis as identified by non-
invasive late gadolinium contrast enhancement (LGE)
CMR and serum biomarkers of fibrosis/ remodeling in a
cohort of DCM patients.
Methods
We investigated 80 DCM patients (50 ± 16 years, 60
males) with known DCM using a 1.5T MRI scanner (Phi-
lips Achieva). Short axis slices covering entirely both ven-
tricles were acquired using a regular SSFP-sequence to
measure ventricular volumes and ejection fraction. Focal
myocardial fibrosis was assessed with LGE CMR images
acquired 10 minutes after i.v. injection of 0.2 mmol/kg
Gd-DTPA (Magnevist). SSFP and LGE CMR images were
assessed by different observers who were blinded to CMR
measurement results and clinical data. Using dedicated
scar software (Philips Viewforum) LGE CMR lesions
were drawn manually on all short axis images and quan-
tified as percent of the total LV mass. The extent of LGE
CMR was correlated to serum markers of fibrosis (Endo-
glin), myocardial necrosis (high sensitivity Troponin T
(hs-TnT)) and heart failure (NT pro-BNP).
Results
LGE CMR lesions were present in 33 patients (41%)
with an average extent of 4±4% and were predominantly
visualized (48%) intra-murally within the septum.
Serum Endoglin and hs-TNT levels were significantly
elevated in LGE CMR patients (6.7±3 ng/ml vs.
5.3±2 ng/ml and 28.3±46 pg/ml vs. 10.7±15 pg/ml; p <
0.02 and 0.04. Only serum levels of Endoglin (area under
the curve (AUC): 0.64; p<0.04) and hs-TnT (AUC:0.66;
p<0.02) but not NT pro-BNP predicted the presence of
LGE CMR.
Conclusions
We provide first evidence that novel serum markers of
interstitial cardiac fibrosis and myocardial necrosis are
elevated in DCM patients with myocardial fibrosis
detected on LGE CMR. The relation between Endoglin
and LGE CMR lesions is especially important, since it
provides novel insights into the pathogenesis of myocar-
dial fibrosis in DCM patients linking interstitial cardiac
fibrosis and markers of smoldering continuous myocar-
dial necrosis to the dys-regulated renin-angiotensin-
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